MX9206614A - Derivados de ariletanolamina, proceso para su preparacion y composicion farmaceutica que los contiene - Google Patents
Derivados de ariletanolamina, proceso para su preparacion y composicion farmaceutica que los contieneInfo
- Publication number
- MX9206614A MX9206614A MX9206614A MX9206614A MX9206614A MX 9206614 A MX9206614 A MX 9206614A MX 9206614 A MX9206614 A MX 9206614A MX 9206614 A MX9206614 A MX 9206614A MX 9206614 A MX9206614 A MX 9206614A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- pharmaceutical composition
- composition containing
- compound
- arylethanolamine derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 1
- -1 amide salt Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919124512A GB9124512D0 (en) | 1991-11-19 | 1991-11-19 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9206614A true MX9206614A (es) | 1994-02-28 |
Family
ID=10704842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9206614A MX9206614A (es) | 1991-11-19 | 1992-11-17 | Derivados de ariletanolamina, proceso para su preparacion y composicion farmaceutica que los contiene |
Country Status (8)
| Country | Link |
|---|---|
| AU (1) | AU2949192A (cs) |
| GB (1) | GB9124512D0 (cs) |
| MX (1) | MX9206614A (cs) |
| NZ (1) | NZ245157A (cs) |
| PT (1) | PT101066A (cs) |
| TW (1) | TW222619B (cs) |
| WO (1) | WO1993010074A1 (cs) |
| ZA (1) | ZA928859B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| TW200740779A (en) * | 2005-07-22 | 2007-11-01 | Mitsubishi Pharma Corp | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
| ITMI20061581A1 (it) | 2006-08-04 | 2008-02-05 | Univ Bari | Ligandi del recettore beta-3 adrenergico e loro uso in terapia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3061334D1 (en) * | 1979-06-16 | 1983-01-20 | Beecham Group Plc | Ethanamine derivatives, their preparation and use in pharmaceutical compositions |
| EP0099707B1 (en) * | 1982-07-16 | 1986-12-10 | Beecham Group Plc | 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them |
| GB8310556D0 (en) * | 1983-04-19 | 1983-05-25 | Beecham Group Plc | Compounds |
| CA2010638A1 (en) * | 1989-03-07 | 1990-09-07 | Leo Alig | Bisphenethanolamines |
-
1991
- 1991-11-19 GB GB919124512A patent/GB9124512D0/en active Pending
-
1992
- 1992-11-17 MX MX9206614A patent/MX9206614A/es unknown
- 1992-11-17 NZ NZ245157A patent/NZ245157A/en not_active IP Right Cessation
- 1992-11-17 PT PT101066A patent/PT101066A/pt not_active Application Discontinuation
- 1992-11-17 ZA ZA928859A patent/ZA928859B/xx unknown
- 1992-11-19 AU AU29491/92A patent/AU2949192A/en not_active Abandoned
- 1992-11-19 WO PCT/GB1992/002135 patent/WO1993010074A1/en not_active Ceased
- 1992-11-20 TW TW081109301A patent/TW222619B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW222619B (cs) | 1994-04-21 |
| ZA928859B (en) | 1994-05-05 |
| PT101066A (pt) | 1994-02-28 |
| WO1993010074A1 (en) | 1993-05-27 |
| GB9124512D0 (en) | 1992-01-08 |
| NZ245157A (en) | 1995-03-28 |
| AU2949192A (en) | 1993-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2076935T3 (es) | Compuesto de pirazolopiridina y procedimientos para su preparacion. | |
| GR3026218T3 (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid | |
| MX9207382A (es) | Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene. | |
| NO930693L (no) | Mometasonfuroatmonohydrat, fremgangsmaate for fremstillingav dette og farmasoeytiske preprater | |
| AR006598A1 (es) | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" | |
| MX9205208A (es) | Compuestos derivados del acido 5-amino-4-hidroxihexanoico, procedimiento para su preparacion y compociciones farmaceuticas que los contienen | |
| ES2155535T3 (es) | Inhibidores de sintesis de apoliproteina b. | |
| MX9307654A (es) | Derivados de amina, proceso para su preparacion y composicion farmaceutica que los contiene. | |
| HUT67661A (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
| MX9305947A (es) | Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. | |
| MX9306311A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| NO304988B1 (no) | 11-benzaldoksim-17<beta>-metoksy-17<alfa>-metoksymetyl-°stradienderivater samt farmas°ytisk preparat inneholdende slike | |
| MX9204318A (es) | Complejos de derivados de pleuromutilina para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9306309A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9206614A (es) | Derivados de ariletanolamina, proceso para su preparacion y composicion farmaceutica que los contiene | |
| NO912414D0 (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
| ES2037095T3 (es) | Un procedimiento para preparar una composicion farmaceutica. | |
| ATE39482T1 (de) | N-(1-ethyl-2-pyrrolidinylmethyl)-benzamidderivate, verfahren und zwischenprodukte zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen. | |
| FI833200A0 (fi) | Isokinolinderivat, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutpreparat och deras anvaendning | |
| ES8307820A1 (es) | Procedimiento para la obtencion de esteres del acido 7b-2-(2amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido-3-cefem-4-carboxilico. | |
| RU95110110A (ru) | Производные бензофурана, способ их получения, фармкомпозиция и способ лечения | |
| ES2043943T3 (es) | Procedimiento para la preparacion de compuestos con actividad analgesica central. | |
| ES2038596T3 (es) | Un procedimiento para la preparacion de nuevos compuestos heterociclicos. | |
| MX9303574A (es) | Compuestos heterociclicos que son inhibidores de la enzima aromatasa, proceso para su preparacion ycomposiciones farmaceuticas que los contienen. | |
| ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. |